z-logo
open-access-imgOpen Access
Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety
Author(s) -
Sharvesh Raj Seeruttun
Publication year - 2019
Publication title -
aims genetics
Language(s) - English
Resource type - Journals
ISSN - 2377-1143
DOI - 10.3934/genet.2019.3.64
Subject(s) - immune system , immunotherapy , cancer , cancer immunotherapy , immune checkpoint , immunology , medicine , cancer research , antigen , cancer cell , antibody , melanoma , ctla 4 , t cell

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom